Akron Children's > For Families & Patients > Research > Pediatric Clinical Studies > Open Clinical Studies
Safety and Efficacy of Plecanatide in Children 6 to < 18 with Irritable Bowel Syndrome with Constipation (IBS-C)
Full IRB Study Title:
A randomized, double-blind, placebo-controlled, dose ranging, parallel-group study of the efficacy and safety of Plecanatide in Children 6 to < 18 Years of Age with Irritable Bowel Syndrome with Constipation (IBS-C) Protocol: SP304202-14
IRB Study ID: 1548588
View complete study details here.
Study Sponsor:
Bausch Health Americas, Inc
